INHIBITION OF VASOPRESSIN-STIMULATED FLANK MARKING BEHAVIOR BY V1-RECEPTOR ANTAGONISTS

被引：67

作者：

FERRIS, CF

SINGER, EA

MEENAN, DM

ALBERS, HE

机构：

[1] VIENNA UNIV, INST PHARMACOL, A-1010 VIENNA, AUSTRIA

[2] GEORGIA STATE UNIV, DEPT BIOL, NEUROENDOCRINOL & BEHAV, ATLANTA, GA 30303 USA

[3] GEORGIA STATE UNIV, DEPT PSYCHOL, ATLANTA, GA 30303 USA

来源：

EUROPEAN JOURNAL OF PHARMACOLOGY | 1988年 / 154卷 / 02期

关键词：

D O I：

10.1016/0014-2999(88)90092-1

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：153 / 159

页数：7

共 21 条

[11] INHIBITION OF FLANK-MARKING BEHAVIOR IN GOLDEN-HAMSTERS BY MICROINJECTION OF A VASOPRESSIN ANTAGONIST INTO THE HYPOTHALAMUS [J].

FERRIS, CF ;

POLLOCK, J ;

ALBERS, HE ;

LEEMAN, SE .

NEUROSCIENCE LETTERS, 1985, 55 (02) :239-243

[12] BIOLOGICAL EVALUATION OF SUBSTANCE-P ANTAGONISTS [J].

FOLKERS, K ;

HAKANSON, R ;

HORIG, J ;

CHENG, XJ ;

LEANDER, S .

BRITISH JOURNAL OF PHARMACOLOGY, 1984, 83 (02) :449-456

[13] PROPERTIES OF RAT ANTERIOR-PITUITARY VASOPRESSIN RECEPTORS - RELATION TO ADENYLATE-CYCLASE AND THE EFFECT OF CORTICOTROPIN-RELEASING FACTOR [J].

GAILLARD, RC ;

SCHOENENBERG, P ;

FAVRODCOUNE, CA ;

MULLER, AF ;

MARIE, J ;

BOCKAERT, J ;

JARD, S .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (09) :2907-2911

[14]

JOHNSTON R E, 1975, Zeitschrift fuer Tierpsychologie, V37, P75

[15] INTERACTION OF RAT ADENOHYPOPHYSEAL VASOPRESSIN RECEPTORS WITH VASOPRESSIN ANALOGS SUBSTITUTED AT POSITIONS 7 AND 1 - DISSIMILARITY FROM THE V1 VASOPRESSIN RECEPTOR [J].

KNEPEL, W ;

GOTZ, D ;

FAHRENHOLZ, F .

NEUROENDOCRINOLOGY, 1986, 44 (03) :390-396

[16] ARGININE VASOPRESSIN AND A VASOPRESSIN ANTAGONIST PEPTIDE - OPPOSITE EFFECTS ON EXTINCTION OF ACTIVE-AVOIDANCE IN RATS [J].

KOOB, GF ;

LEMOAL, M ;

GAFFORI, O ;

MANNING, M ;

SAWYER, WH ;

RIVIER, J ;

BLOOM, FE .

REGULATORY PEPTIDES, 1981, 2 (03) :153-163

[17] CENTRAL INJECTIONS OF ARGININE VASOPRESSIN PROLONG EXTINCTION OF ACTIVE-AVOIDANCE [J].

KOOB, GF ;

DANTZER, R ;

BLUTHE, RM ;

LEBRUN, C ;

BLOOM, FE ;

LEMOAL, M .

PEPTIDES, 1986, 7 (02) :213-218

[18] [1-(BETA-MERCAPTO-BETA,BETA-CYCLOPENTAMETHYLENEPROPIONIC ACID),2-(O-METHYL)TYROSINE]ARGININE-VASOPRESSIN AND [1-(BETA-MERCAPTO-BETA,BETA-CYCLOPENTAMETHYLENEPROPIONIC ACID)]ARGININE-VASOPRESSIN, 2 HIGHLY POTENT ANTAGONISTS OF THE VASOPRESSOR RESPONSE TO ARGININE-VASOPRESSIN [J].

KRUSZYNSKI, M ;

LAMMEK, B ;

MANNING, M ;

SETO, J ;

HALDAR, J ;

SAWYER, WH .

JOURNAL OF MEDICINAL CHEMISTRY, 1980, 23 (04) :364-368

[19] VASOPRESSIN PRESSOR ANTAGONIST INJECTED CENTRALLY REVERSES BEHAVIORAL-EFFECTS OF PERIPHERAL INJECTION OF VASOPRESSIN, BUT ONLY AT DOSES THAT REVERSE INCREASE IN BLOOD-PRESSURE [J].

LEBRUN, C ;

LEMOAL, M ;

KOOB, GF ;

BLOOM, FE .

REGULATORY PEPTIDES, 1985, 11 (02) :173-181

[20] SUBSTANCE P-ANTAGONISTS - A NEW TYPE OF PHARMACOLOGICAL TOOL [J].

ROSELL, S ;

FOLKERS, K .

TRENDS IN PHARMACOLOGICAL SCIENCES, 1982, 3 (05) :211-212

← 1 2 3 →